The host mTOR pathway and parasitic diseases pathogenesis

Area of Science:

• Cell Biology
• Immunology
• Parasitology

Background:

• The mechanistic target of rapamycin (mTOR) is a key regulator of cell growth, metabolism, and homeostasis.
• mTOR signaling is intricately linked with autophagy and immune responses.
• Dysregulation of mTOR is implicated in various diseases, including cancer and diabetes.

Purpose of the Study:

• To review the role of mTOR signaling in host-pathogen interactions, particularly in parasitic infections.
• To explore how parasites modulate the mTOR pathway.
• To discuss the therapeutic potential of targeting mTOR in parasitic diseases.

Main Methods:

• Literature review of studies on mTOR signaling, autophagy, and parasitic infections.
• Analysis of mechanisms by which parasites interact with the mTOR pathway.
• Examination of the effects of mTOR inhibition in the context of parasitic diseases.

Main Results:

• Parasitic infections can induce significant metabolic reprogramming, leading to alterations in mTOR signaling.
• Parasites employ diverse strategies to modulate the host's mTOR network.
• mTOR pathway modulation by parasites impacts host immunity and pathogenesis.
• Inhibiting mTOR shows potential for preventing and treating parasitic diseases.

Conclusions:

• mTOR signaling is a critical nexus in host-parasite interactions.
• Understanding parasite-induced mTOR alterations can reveal parasite biology.
• Targeting mTOR represents a promising therapeutic avenue for combating parasitic infections.